Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

118 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-21

Study Completion Date

2020-11-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess how a polygenic risk score (PRS) reported with the results of multi-gene panel testing affects the breast cancer risk management recommendations healthcare providers make to their patients. The PRS is a score based on small genetic changes, clinical history, and family history. The PRS is used to estimate remaining lifetime risk of developing breast cancer for patients with no personal history of breast cancer and an overall negative result from MGPT.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Implementing Polygenic Risk Scores for Breast Cancer Prevention: a Feasibility Study

NCT06922708

Breast Cancer

NOT_YET_RECRUITING NA

Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study

NCT04474834

Breast Cancer

ENROLLING_BY_INVITATION

Combined Breast Cancer Risk Study

NCT03067389

Hereditary Cancer

COMPLETED

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

NCT00897455

brca1 Mutation Carrier brca2 Mutation Carrier Breast Cancer

UNKNOWN

Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

NCT00899145

BRCA1 Mutation Carrier BRCA2 Mutation Carrier Breast Carcinoma

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Risk

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female, age ≥ 18 years
* Willing and able to provide meaningful informed consent
* Willing and able to complete study procedures as described in this protocol
* Electing to undergo multi-gene panel testing for hereditary breast cancer for clinical purposes at the time of consent
* No personal history of cancer (except non-melanoma skin cancer) and meets NCCN guidelines for BRCA1/2 testing based on family history of breast and/or ovarian cancer
* Meets Ambry criteria for clinical reporting of PRS score

Exclusion Criteria

* Prior germline BRCA1/2 testing
* Not willing to receive PRS
* Personal history of cancer, except non-melanoma skin cancer
* Personal history of allogenic bone marrow/stem cell transplant

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No